Pharmacotherapy of Obesity

Obesity has become a major epidemic that now rivals smoking as a risk to public health. The ensuing epidemics of diabetes, vascular disease and other complications are set to overwhelm the healthcare systems of wealthy and poorer nations alike. The need for effective pharmacotherapy has never been g...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Wilding, John P. H., SpringerLink (Online service)
Formato: Digital
Publicado em:
Assuntos:
Endereço do item:http://dx.doi.org/10.1007/978-3-7643-7425-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
id oai:localhost:123456789-212589
record_format dspace
spelling oai:localhost:123456789-2125892023-07-17T15:09:20Z Pharmacotherapy of Obesity Wilding, John P. H. SpringerLink (Online service) Toxicologia. Cardiologia. Diabetes. Distúrbios do metabolismo. Citologia. Biomedicina. Obesity has become a major epidemic that now rivals smoking as a risk to public health. The ensuing epidemics of diabetes, vascular disease and other complications are set to overwhelm the healthcare systems of wealthy and poorer nations alike. The need for effective pharmacotherapy has never been greater. This book takes a new look at the many potential targets for drug development for regulation of body weight, placing them in the context of the chequered history of drug development for obesity and currently available therapies. Potential peripheral and central nervous system targets are discussed in detail by authors with extensive knowledge and research experience in the science of body weight regulation, and its translation into effective therapies that will benefit patients. This book is of interest to clinicians, researchers in the field and members of the pharmaceutical industry who are interested in learning more about the current state of the art and future directions in the pharmacotherapy of obesity. 0 2022-10-11T17:42:57Z 2022-10-11T17:42:57Z 2008. Digital 615 23 9783764374259 198677 http://dx.doi.org/10.1007/978-3-7643-7425-9 http://dx.doi.org/10.1007/978-3-7643-7425-9
institution Acervo SISBI
collection SIGAA
topic Toxicologia.
Cardiologia.
Diabetes.
Distúrbios do metabolismo.
Citologia.
Biomedicina.
spellingShingle Toxicologia.
Cardiologia.
Diabetes.
Distúrbios do metabolismo.
Citologia.
Biomedicina.
Wilding, John P. H.
SpringerLink (Online service)
Pharmacotherapy of Obesity
description Obesity has become a major epidemic that now rivals smoking as a risk to public health. The ensuing epidemics of diabetes, vascular disease and other complications are set to overwhelm the healthcare systems of wealthy and poorer nations alike. The need for effective pharmacotherapy has never been greater. This book takes a new look at the many potential targets for drug development for regulation of body weight, placing them in the context of the chequered history of drug development for obesity and currently available therapies. Potential peripheral and central nervous system targets are discussed in detail by authors with extensive knowledge and research experience in the science of body weight regulation, and its translation into effective therapies that will benefit patients. This book is of interest to clinicians, researchers in the field and members of the pharmaceutical industry who are interested in learning more about the current state of the art and future directions in the pharmacotherapy of obesity.
format Digital
author Wilding, John P. H.
SpringerLink (Online service)
author_facet Wilding, John P. H.
SpringerLink (Online service)
author_sort Wilding, John P. H.
title Pharmacotherapy of Obesity
title_short Pharmacotherapy of Obesity
title_full Pharmacotherapy of Obesity
title_fullStr Pharmacotherapy of Obesity
title_full_unstemmed Pharmacotherapy of Obesity
title_sort pharmacotherapy of obesity
publishDate 2022
url http://dx.doi.org/10.1007/978-3-7643-7425-9
work_keys_str_mv AT wildingjohnph pharmacotherapyofobesity
AT springerlinkonlineservice pharmacotherapyofobesity
_version_ 1771689074033164288